Literature DB >> 3891878

Human cutaneous graft-versus-host disease.

E R Farmer.   

Abstract

The natural history of human cutaneous graft-versus-host disease (GVHD) has been described as a consequence of allogeneic bone-marrow transplants, but syngeneic and even autologous marrow transplants are now being recognized as being associated with similar, albeit less severe, changes. The histopathologic changes of both acute and chronic GVHD have been reported and show similarities to other idiopathic cutaneous disorders. The T-lymphocyte, specifically an OKT8+ cell, seems to play a major role in the pathogenesis of cutaneous GVHD. A recently described in vitro model of human cutaneous GVHD using skin explants co-cultured with lymphocytes holds some promise as a technique to further explore lymphocyte-skin interactions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891878     DOI: 10.1111/1523-1747.ep12275636

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

Review 1.  Oral graft-versus-host disease.

Authors:  M M Imanguli; I Alevizos; R Brown; S Z Pavletic; J C Atkinson
Journal:  Oral Dis       Date:  2008-07       Impact factor: 3.511

Review 2.  Treatment of lichen planus.

Authors:  G F Oliver; R K Winkelmann
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

Review 3.  Graft versus leukemia in bone marrow transplantation.

Authors:  M Boranić
Journal:  Blut       Date:  1988-08

4.  Drug-induced skin reactions and acute cutaneous graft-versus-host reaction: a comparative immunohistochemical study.

Authors:  M Drijkoningen; C De Wolf-Peeters; G Tricot; H Degreef; V Desmet
Journal:  Blut       Date:  1988-02

Review 5.  Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review.

Authors:  Cesar Daniel Villarreal Villarreal; Julio Cesar Salas Alanis; Jose Carlos Jaime Pérez; Jorge Ocampo Candiani
Journal:  An Bras Dermatol       Date:  2016 May-Jun       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.